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Abstract 25 
This study compares iron (Fe) absorption in Fe-deficient animals from bread 26 
formulations prepared by substitution of white wheat flour (WB) by whole wheat flour 27 
(WWB), amaranth flour (Amaranthus hypochondriacus, 25%) (AB) and quinoa flour 28 
(Chenopodium quinoa, 25%) (QB), or chia flour (Salvia hispanica L, 5%) (ChB). 29 
Hematological parameters of Fe homeostasis, plasmatic active hepcidin peptide 30 
production (LC coupled to Ms/Ms), and liver TfR-2 and IL-6 expression (RT-qPCR) 31 
were determined. The different bread formulations increased Fe content between 14% 32 
and 83% relative to white bread. Only animals fed with WWB, AB and ChB increased 33 
significantly haemoglobin concentrations. Feeding the different bread formulations did 34 
not increase hepcidin levels, but down-regulated TfR2 (except WWB) and IL-6 (except 35 
QB) expression levels. Only AB and ChB had significant influence favoring on Fe 36 
bioavailability at the investigated level of substitution. The potential contribution of 37 
these flours would not differ considerably from that of WWF. 38 
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1. Introduction 42 
Iron (Fe) deficiency is a major cause of detrimental health effects in children and 43 
women of reproductive age because, among other, impairing mental and psychomotor 44 
development, increasing both morbidity and mortality of mother and child and 45 
decreasing work performance.
1
 This worldwide health problem shows that Fe-46 
deficiency continues to be a problem and points to the need of developing preventive 47 
nutritional intervention strategies in relation to this micronutrient. A desirable, easy and 48 
low cost strategy to prevent Fe-deficiency is, when possible, dietary diversification to 49 
promote the consumption of available mineral-rich foods. 50 
Cereals constitute a good source of iron and bread, as staple food with high 51 
consumption frequency, can serve as a good vehicle to combine those with natural 52 
ingredients improving its nutritional value. Nutritional and chemical composition 53 
analyses indicate that the pseudocereals, among other, amaranth (Amaranthus cruentus) 54 
and quinoa (Chenopodium quinoa), as well as oliseeds such as chia (Salvia hispanica L) 55 
can represent a healthier alternative to frequently used wheat grain in bread 56 
formulations. Thus, it has been reported that the amount of minerals as calcium), 57 
magnesium, iron and zinc  in amaranth seeds are 5.2-, 2.9-, 2.8- and 1.3-fold higher than 58 
in wheat grain, respectively.
2
 Whole amaranth flour (WAF) used in bread formulation 59 
increases the Fe content in bread samples up to 2.3-fold (43.8 μg/g) in comparison to 60 
white bread.
 3
 There have been quantified 29.5 g/g Fe concentrations in quinoa grains 61 
that are higher than those values found in rice (13.2 g/g) and finger millet (21.3 g/g). 62 
4
 In this line, the oilseed chia is also a good source of Fe (164.0 mg/g) and once 63 
processed its flour can provide up to 20.4 mg/g.
 5
 Additionally, the breads containing 64 
pseudocereals have also significant higher levels of protein, fat and fibre than white 65 
bread, even at low levels of substitution. Moreover, the attributes of these breads 66 
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conform to the expert's nutritional recommendations for the gluten-free diet and gluten-67 
free foods. 68 
Only scarce in vivo studies have been performed about to what extent the 69 
pseudocereals (amaranth or quinoa) impact the nutritional iron status.
 6,7
 Currently, it is 70 
assumed the higher nutritional value of pseudocereals and the oilseed chia; however, 71 
there is a lack of data supporting their positive influence improving the nutritional Fe 72 
status of iron-deficient experimental models. Pseudocereals as well as conventional 73 
cereals carry a significant amount of phytic acid, a potent inhibitor of Fe bioavailability. 74 
8,9
 However, the absorption of dietary Fe is also regulated by physiological factors, 75 
among other, bioactive hepcidin peptide.
 10-12
 The latter is a key regulator of Fe 76 
metabolism associated to acute phase inflammatory processes within the gut-liver axis. 77 
11,13 
However, understand the interaction of phytic acid and hepcidin on Fe absorption is 78 
not straightforward. For example, there have been reported similar percentages of Fe 79 
absorption in girls and boys after consumption of two different diets with a 2.6-fold 80 
unfavourable ratio phytic acid/Fe.
 6
 Phytic acid has shown to exhibit protective action 81 
and attenuate inflammation in several different rodent models of Parkinson’s disease 14 82 
and cancer 
15
. These diseases constitute pathological conditions where hepcidin plays an 83 
important role favouring metal dyshomeostasis and inflammation. 
16,17
 84 
Although there is a number of differences concerning Fe absorption in rats compared 85 
with humans limiting their predictive value in relation to human responses, 
18
 it is worth 86 
to study and understand the phytic acid-Fe interactions in foods with high nutritional 87 
potential. Herein, it was used a nutritionally-induced iron deficient animal model that 88 
exhibits comparable responses of regulatory factors of systemic Fe homeostasis that 89 
involve liver transferrin receptor-2 and hepcidin. 
11,12,19
 90 
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The present study evaluated the absorption of Fe contained in several different bread 91 
formulations containing amatranth, quinoa or chia. The different bread formulations 92 
were also compared according to their influence on hepatic pro-inflammatory hepcidin 93 
peptide secretion that exerts a critical control on intestinal Fe absorption and hepatic 94 
metabolism. 95 
 96 
2. Material and methods 97 
2.1 Breadmaking. Commercial Spanish wheat flour and whole wheat flour were 98 
purchased from the local market (La Meta, S.A., Spain) as well as quinoa kernels 99 
(Chenopodium quinoa) (Ecobasic – Bio, S.L., Spain), amaranth kernels (Amaranthus 100 
hypochondriacus) (Corporación Proteína Americana, SCRL, Tehuacán Puebla, Mexico) 101 
and chia seeds (Salvia hispanica) (Primaria Raw Matrials, Valencia-Spain). 102 
Compressed yeast (Saccharomyces cerevisiae, Levamax, Spain) was used as a starter in 103 
identical breadmaking processes according to previously established processes. 
3,20,21
 104 
2.2 Determination of phytates. InsP6 present in flours and the remaining InsP6 in 105 
bread were purified by ion-exchange chromatography and measured by the HPLC 106 
method described by Sanz-Penella et al. 
3
 Identification of phytates was achieved by 107 
comparison with standards of phytic acid di-potassium salt (Sigma-Aldrich, St. Louis, 108 
MO). Samples were analyzed in triplicate. 109 
2.3 Determination of iron. The total Fe concentration in bread samples was 110 
determined using a flame atomic absorption spectrometer at the Servei Central de 111 
Suport a la Investigació Experimental from the Universitat de València. Previously, 112 
samples were placed in a Teflon perfluoroalkoxy (PFA) vessel and treated with 1 ml 113 
HNO3 (14 M, Merck) and 1 ml of H2O2 (30 % v/v, Panreac Quimica, Spain). The 114 
Teflon PFA vessel was irradiated at 800 W (15 min at 180ºC) in a microwave 115 
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accelerated reaction system (MARS) from CEM (Vertex, Spain). At the end of the 116 
digestion program, the digest was placed in a tube and made up to volume with 0.6 M 117 
HCl (Merck). Samples were analyzed in triplicate (n=3). 118 
2.4 Animals. Forty-two female Wistar albino rats, aged 3 weeks with an average 119 
weight of 61.4  5.6 g were obtained from the University of Valencia Animal Service. 120 
Animal experiments were carried out in strict accordance with the recommendations 121 
included in the Guide for the Care and Use of Laboratory Animals of University of 122 
Valencia (SCSIE, University of Valencia, Spain) and the protocol was approved by its 123 
Ethic Committee (A1351244049254). 124 
2.5 Experimental design. Animals were randomly distributed into eight different 125 
groups (n=7 per group), (1) a control group receiving a standard AIN-93G diet, and 126 
seven iron-deficient groups receiving a AIN-76A diet (Harlan) for 15 days that were 127 
subjected to different treatments: (2) iron-deficient group; (3) administered with FeCl3 128 
(2.5 mg), or administered with different bread formulations to provide a similar amount 129 
of the micronutrient, (4) white bread; (5) amaranth flour-containing bread; and (6) chia 130 
flour-containing bread; (7) quinoa flour-containing bread; and (6) whole wheat flour-131 
containing bread. A 0.1 g aliquots of the different samples were administered 132 
intragastrically (gavage) three times per day during two consecutive days. The rats were 133 
maintained in an environment of controlled temperature (21–23 ºC), humidity (55%) 134 
and light (12 h)–dark (12 h) cycle, with ad libitum food and mineral-free water 135 
available. Records of weight and food intake were collected daily. After treatment, rats 136 
were anaesthetised (isofluran) and sacrificed by exsanguination. Whole blood samples 137 
were preserved in EDTA-treated tubes for haematological analyses and the rest of the 138 
blood was used for hepcidin peptide quantification. Sections (±100 mg) of the liver 139 
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were immersed in RNA later buffer (Qiagen, CA, USA) and snap-frozen in liquid 140 
nitrogen for gene expression analyses. 141 
2.6 Hemoglobin (Hb) measurement. Hb concentrations were measured 142 
photometrically using cyanmethemoglobin standard solution according to the 143 
manufacturer’s instructions (Sigma-Aldrich). This method is based on the oxidation of 144 
Hb and its derivatives (except sulfhemoglobin) to methemoglobin in the presence of 145 
potassium ferricyanide to form cyanmethemoglobin. The absorbance, measured at 540 146 
nm, is proportional to the total Hb concentration. 147 
2.7 Hematological parameters.
 
The number of erythrocytes was calculated by 148 
using a Neubauer improved cell counting chamber and hematocrit was estimated by 149 
centrifugation of whole blood in microcapillar tubes. The mean corpuscular volume 150 
(MCV) was calculated using the following equation: (hematocrit x 10)/number of 151 
erythrocytes (10
6
 per mm
3
 blood), and mean corpuscular Hb (MCH) (%) as: 152 
(hemoglobin (g/dL) x 100)/hematocrit. The globular sedimentation speed (VSG) was 153 
determined according to Westergren's method as proposed by the International Council 154 
for Standardization in Hematology (ICSH). 155 
2.8 Reverse transcription and real-time PCR analyses. 
12 
Total RNA was 156 
extracted from liver tissue samples using an RNeasy mini kit (Qiagen, USA) following 157 
the protocol provided by the manufacturer. One microgram of total RNA was converted 158 
to double-stranded cDNA using AMV Reverse Transcriptase (Promega, USA). PCR 159 
was performed with primers designed for the following Rattus norvegicus genes: TfR2 160 
(forward: 5’- GGC AGA GTG GTC GCT GGG TG -3’; reverse: 5’- GGC CAG AGC 161 
TCG GCA GTG TG -3’); IL-6 (forward: 5´-TCT CGA GCC CAC CAG GAA C -3´; 162 
reverse: 5´-AGG GAA GGC AGT GGC TGT CA -3´) and β-actin (forward 5’- CTC 163 
TTC CAG CCT TCC TTC CT-3’; reverse 5’- TAG AGC CAC CAA TCC ACA CA-164 
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3’), the latter was used as a housekeeping gene. The PCR mix (20 L reaction volume) 165 
consisted of 7.5 L SYBR Green I master mix, 1.3 mol/L primers, and 2.5 L cDNA. 166 
PCR reactions were performed in triplicate in a LightCycler
®
 480 (Roche) with the 167 
following program: 1 cycle at 95 ºC for 5 min, 35 cycles at 60 ºC for 20 s and 72 ºC for 168 
45 s. The relative mRNA expression of the tested genes was normalized using -actin as 169 
housekeeping gene applying the 2
-Cp
.  170 
2.9 Quantification of hepcidin in plasma (LC-Ms/Ms). All sample preparation 171 
steps were performed at room temperature as previously described. 
11
 Aliquots (50 µL) 172 
of plasma were pipetted into 200 µL cone tubes and a 100 µL aliquot of acetonitrile 173 
(Burdick and Jackson, Muskegon, MI) was added to each tube and mixed by pipetting. 174 
The samples were then centrifuged at 3,000 xg for 10 minutes at 4°C (Jouan, 175 
Winchester, VA). After centrifugation, the protein precipitation supernatant (100 µL) 176 
was mixed with 0.02% (v/v) aqueous acetic acid and injected on an Agilent HPLC 177 
system connected on line to an Esquire-LC electrospray system equipped with a 178 
quadrupole ion trap mass spectrometer (Bruker Daltonics, Billerica, MA). The HPLC 179 
system was equipped with a quaternary pump, an in-line degasser, an automatic 180 
injector, and a variable wavelength absorbance detector set at 214 nm (1100 Series, 181 
Agilent Technologies, Waldbronn, Germany). The column used in these analyses was a 182 
BioBasic C18 5 µm 4.6x250 mm (Thermo, Waltham, MA, USA). The mobile phases 183 
consisted of trifluoroacetic acid/isopropanol/water (0.125/1/500) (A) and trifluoroacetic 184 
acid/isopropanol/water/methanol/acetonitrile (0.125/1/50/350/100) (B). Aliquots (50 185 
µL) of the precipitation supernatants were injected in each cycle and the analysis was 186 
performed with the following gradient (minutes, %B): 0, 5; 30, 90; 33, 100; 35, 0; 40, 187 
90; 45, 5. 188 
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The m/z spectral data were processed and transformed to spectra representing mass 189 
values using the program Data Analysis version 3.0 (Bruker Daltonics). BioTools 190 
version 2.1 (Bruker Daltonics) software was used to process the Ms/Ms spectra and to 191 
perform peptide sequencing. Two independent samples from each animal were 192 
analyzed. 193 
2.10 Statistical analysis. Statistical analyses were performed using SPSS v.15 194 
software (SPSS Inc., Chicago, IL, USA). One-way analysis of variance (ANOVA) and 195 
the Tukey post hoc test were applied. Variance analysis by one-way method was used to 196 
compare the influence of feeding different bread formulations in the iron-deficient 197 
groups of animals. Individual means were tested using pair-wise comparison with 198 
Tukey's multiple comparison test when effects were significant. Statistical significance 199 
was established at P<0.05 for all comparisons. Data are expressed as mean ± standard 200 
deviation. 201 
 202 
3. Results 203 
3.1 Micronutrient contribution of bread formulations and influence on 204 
hematological parameters. Total iron (Fe) and phytate (InsP6) content in different 205 
bread formulations are shown in Table 1. Substitution of wheat flour by the different 206 
types of flour increased Fe content between 14% and 83% relative to control (white 207 
bread, WB). The concentration of InsP6 also increased following the gradation: AB > 208 
WWB > QB > ChB. However, concentration of InsP6 was below the quantification limit 209 
in WB samples. When considering the total Fe contents and InsP6 concentration in the 210 
different bread formulations there can be calculated values for the ratio InsP6/Fe that 211 
are ranged between 1.6 and 4.7. These values are markedly higher than the critical value 212 
(>1) established as inhibitory for Fe uptake. 
22
 Thus, there can be expected low 213 
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bioavailability values for the micronutrient from bread formulations with the different 214 
flours from the pseudocereals (amaranth and quinoa) or chia used. 215 
Animals fed with the iron-deficient diet alone exhibited significant lower 216 
hemoglobin (Hb) concentrations in relation to control animals (Table 2). In agreement 217 
with previous studies there was detected no significant alterations in the hematocrit 
12
 218 
that is estimated to appear feeding the iron-deficient diet for longer periods (>20 days). 219 
23
 Nevertheless, there was a significant decrease in the mean corpuscular hemoglobin 220 
concentration (MCH) (P < 0.05) in animals receiving the Fe-deficient diet. Animals 221 
administered with the supplement of Fe alone showed significant increases in Hb (46%) 222 
and MCH (42%). Whereas iron deficient (ID) animals fed with AB and ChB also 223 
showed increased Hb concentration those fed WWB as well as WB or QB did not 224 
increased their Hb values indicating the lower bioavailability of the micronutrient from 225 
these samples. Only those animals fed ChB showed significant increases in MCH 226 
values; however, all other groups of treatment showed increasing trends (p>0.05) for 227 
MCH values. In ID animals, MCV values were increased in those groups administered 228 
with AB, ChB and QB. There were not detected significant (P>0.05) differences neither 229 
in body weight nor number of erythrocytes among the different experimental animal 230 
groups (data not shown). 231 
3.2 Influence of bread formulations on plasma active hepcidin peptide and 232 
hepatic biomarkers. The active hepcidin peptide was identified by sequencing its 233 
amino acid backbone by using a previously optimized protocol for analysis in rat serum 234 
11
 (Figure 1). The consumption of the ID diet did not cause significant (P>0.05) 235 
alterations in bioactive hepcidin peptide production relative to control animals. Notably, 236 
animals administered with the supplement of Fe alone exhibited significantly increased 237 
(1.4-fold) circulating hepcidin concentrations. Animals administered with the different 238 
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bread formulations did not provoke significant elevations in the circulating 239 
concentration of hepcidin demonstrating the physiological liver inflammatory response 240 
associated to intrahepatic iron accumulation. 
11
 Serum hepcidin displays an inverse 241 
relationship with Fe intestinal absorption either from foods or dietary supplements. 
10
 242 
Changes in hepatic transcripts (mRNA) of transferrin receptor (Tfr)-2 and 243 
interleukin (IL)-6 in the different groups of treatment are shown in Figure 2. The 244 
administration of all bread formulations, except WWB, down-regulated the expression 245 
levels of Tfr2 that relies information on plasmatic concentrations of the micronutrient. 
24
 246 
Overall, animals from the different groups of treatment showed down-regulated 247 
expression levels of IL-6 that is a key inducer of hepatic acute-phase protein production 248 
and plays an important role in haematopoiesis, inflammation and immune regulation. 
13
 249 
 250 
4. Discussion 251 
Pseudocereals and oilseeds are increasingly used to obtain flours and supplement 252 
bread formulations in order to improve their nutritional value. The quantification of 253 
total Fe in the analyzed bread formulations is in good agreement with previous studies 254 
supporting the nutritional profiles of quinoa (Chenopodium quinoa), amaranth 255 
(Amaranthus Caudatus) 
21,25,26,27
, and chia as rich sources of the micronutrient. 
20
 In the 256 
scientific literature scarce in vivo studies evaluated the impact of amaranth grains 
3,7
 or 257 
quinoa on the nutritional iron status. 
6
 In accordance with these previous studies the data 258 
reported in this study point out significant differences in Fe bioavailability from the 259 
different bread formulations. These differences are supported by the different ratios 260 
(values from 0.76 to 1.1) that can be calculated between Hb concentrations in animals 261 
fed with bread formulations and those administered with a reference dose of inorganic 262 
Fe. Previous data from experimental models also reported a low or negligible influence 263 
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of amaranth improving the bioavailability of the micronutrient to growing Sprague-264 
Dawley weaning male rats. 
28,29
 Intervention studies in human subjects without ID that 265 
were fed with cereals fortified with 2.5 mg Fe as FeSO4 it was also demonstrated low 266 
bioavailability values (<1%) for the several different cereals studied, among other, bitter 267 
and sweet quinoa. 
6
 Additional data from human studies confirmed a 1.6-fold higher Fe 268 
absorption ratio from wheat than quinoa infant cereals 
8
 that results similar to the 1.1-269 
fold higher Hb concentration found in ID animals fed with WWB in relation to QB. 270 
An important variable, when monitoring iron absorption for different cereal grains, is 271 
the nature and phytic acid (or phytates) concentration of the sample. In this study it was 272 
observed significant differences in InsP6 concentration between the different breads that 273 
were not reflected in significant changes in Hb. For example, amaranth flour provided 274 
4.6-fold higher InsP6 content than flour from chia (Table 1), but animals administered 275 
with bread formulations containing either amaranth or chia showed similar Hb 276 
concentrations (Table 2). However, both bread formulations improved the nutritional 277 
status of animals in relation to ID animals and those administered with white bread. 278 
These results contrast with the scarce studies existing where it is shown that 279 
supplementation with amaranth did not increased Fe absorption despite a large increase 280 
in iron intake (by 5.6-fold) and more favourable phytate:iron molar ratio (3:1 versus 281 
5:1) than controls after an intervention period of 16-wk. 
28,29
 In the majority of 282 
published studies about the negative interaction of phytate on Fe bioavailability, there 283 
has been established a desirable ratio InsP6/Fe of <0.4/1 as a critical value determining 284 
the inhibitory effect of phytate. 
9
 Thus, the addition of amaranth grain flour to maize-285 
based porridge did not improve the nutritional Fe status in ID children. 
7
 In vitro studies 286 
have shown that can be defined a critical proportion of amaranth flour to be used in 287 
bread formulations favouring Fe bioavailabilty as indicated by the ferritin 288 
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concentrations quantified in cell cultures. 
3
 The bioaccessible phytate/Fe molar ratio 289 
rather than phytate content in the bread samples explained the amaranth flour-mediated 290 
inhibitory effect on the available Fe. There has been reported in the literature a great 291 
disparity in the concentration of phytates in amaranth grains (4.8-34.0 µmol/g). 3,30 In 292 
the present study, the amount of InsP6 in the bread with 25% of amaranth was 3.7 293 
μmol/g and seemed to exert low inhibitory effects on Fe bioavailability. Thus, allowing 294 
us to hypothesize that low InsP6 concentrations are released during duodenal transit 295 
where it takes place most of micronutrient uptake. Additionally, in vitro studies 296 
evidenced that simple carbohydrates such as fructose can increase Fe uptake in human 297 
intestinal Caco-2 and HepG2 cells based on protein ferritin synthesis. 
31
 These studies 298 
are in line with recent experimental data demonstrating that structural differences of 299 
prebiotic fibres influence Fe uptake to ID animals. 
12
 Thus, studies in this line are 300 
advisable to understand the nutritional implications of their use in bread formulations 301 
given that pseudocereals have been suggested as healthier alternatives to white bread to 302 
better control the glycemic index. 
32
 303 
Inflammation is an important contributor to the development of chronic diseases. 304 
Thus, it was examined whether ancient Latin-American crops-containing bread 305 
formulations were associated with lower concentrations of inflammatory markers, 306 
which play a key role in intestinal Fe absorption and liver metabolism. The observation 307 
that pseudocereals-based bread formulations decreased plasmatic levels of hepcidin 308 
bioactive peptide (Fig. 2) suggests that the release from bread formulations of a high 309 
proportion of compounds able to chelate the micronutrient preventing the hepcidin-310 
mediated inhibition of intestinal absorption. This suggestion is supported by the down-311 
regulation of mRNA expression levels of TfR2 (Fig. 2) that serves as a body Fe sensor 312 
of plasmatic concentration of the micronutrient. 
11,24
 Decreased concentrations of TfR 313 
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have also been quantified in ID children even after they received a multi-micronutrient 314 
powder (2.5 mg Fe/day). 
7
 Experimental models as well as human studies have 315 
demonstrated the inverse relationship between serum hepcidin concentration and Fe 316 
absorption from food and supplemental sources. 
10,11
 The low inflammatory potential 317 
estimated for the pseudocereals is in line with the reported anti-inflammatory effects of 318 
amaranth 
33
 and quinoa 
34
 in THP-1 human-like and mouse RAW 264.7 macrophages. 319 
Anti-inflammatory effects of pseudocereals could be probably attributed to the 320 
production of bioactive peptides or released saponins during processing. Additionally, 321 
human studies demonstrated that quinoa is well tolerated by patients with inflammatory 322 
autoimmune-based intestinal disorders such as celiac disease. 
35
 The low inflammatory 323 
potential of pseudocereals is reflected in the low transcripts (mRNA) of IL-6 (Fig. 2) 324 
that can have important nutritional consequences. It has been previously reported an 325 
inverse association of IL-6 levels with plasma Fe concentration and transferrin 326 
saturation together with increased ferritin in the liver. 
36
 Recent human data 327 
demonstrated the critical influence of quantity and quality of dietary carbohydrates 328 
favouring increased concentrations of pro-inflammatory cytokines such as IL-6. 
37
 329 
 330 
5. Conclusions 331 
Most of existing data supporting beneficial nutritional effects of pseudocereals are 332 
based on their high content of nutrients, among other minerals. Notably, Fe absorption 333 
studies from both experimental and human intervention trials indicate poor 334 
bioavailability of the micronutrient from cereals. The data reported herein, on the 335 
administration of different bread formulations to iron deficient animals, show 336 
differences in Fe bioavailability. Except WWB and QB, bread formulations made with 337 
amaranth (AB) or chia (ChB) improved the Hb concentrations in relation to the WB. 338 
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However, taking into account the high content of minerals in the pseudocereals or chia, 339 
the potential contribution of these whole flours would not differ considerably from that 340 
of wheat flour. Notably, these data point out that incorporation of functional ingredients 341 
like pseudocereals/chia in bread making strategies is associated with a positive 342 
inflammatory profile preventing the hepcidin-mediated inhibition of Fe uptake at 343 
intestinal level. Further studies and human trials are needed to gain a better 344 
understanding of the potential nutritional influence of the carbohydrates-Fe interaction 345 
when using these flours in bread making strategies. 346 
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Table 1. Iron and phytates (InsP6) content in breads formulated with flours from 472 
different origin. Values are expressed as mean  standard deviation (n=3). a-e Different 473 
letters in the same column indicate statistical differences (P<0.05). WB, white bread; 474 
WWB, whole wheat bread; AB, bread with 25% amaranth flour; ChB, bread with 5% 475 
chia whole flour; QB, bread with 25% of quinoa whole flour. 476 
Sample Iron (mol/g) InsP6 (mol/g) InsP6/Iron 
1
 
WB 0.42 ± 0.05
 a
 n.d. -- 
WWB 0.67 ± 0.03
 b
 2.57 ± 0.12
 b
 3.8˃1 
AB 0.77 ± 0.08
 c
 3.65 ± 0.38
 c
 4.7˃1 
ChB 0.48 ± 0.02
 a
 0.75 ± 0.03
 a
 1.6˃1 
QB 0.61 ± 0.01
 ab
 2.04 ± 0.04
 b
 3.3˃1 
1
 A maximum critical value of 1 has been established for the molar ratio InsP6/Iron as 477 
inhibitory for Fe uptake (Hurrell, 2004). 478 
 479 
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Table 2. Haematological parameters in iron-deficient (ID) and animals fed with FeCl3 alone or together with different bread samples
a
.  
 
  Treatment  
Control ID FeCl3
b 
WB WWB AB ChB QB 
Haemoglobin 
(Hb, g/dL) 
18.9 a 11.12.7b 16.20.2a 12.30.2b 14.71.3ab 16.42.2a 17.42.8a 13.42.9ab 
Haematocrit 54.3 a 46.92.6a 51.2±2.5a 52.02.4a 49.03.9a 54.24.2a 55.9  5.2a 61.3  7.3a 
MCV (x10
-4
) 1.680.04a 1.64 0.04a 1.710.04a 1.690.04a 1.700.04a 1.970.04bc 1.910.04b 2.070.04c 
MCH (pg) 33.7±2.1a 20.35.5b 28.90.3a 25.35.9ab 27.94.6ab 26.24.1ab 31.25.0b 21.94.8ab 
a
Values are presented as mean  standard deviation (n=5). Values following by the same letter in the same line are not statistically different (P<0.05). WB, white bread; 
WWB, whole wheat bread; AB, bread with 25% amaranth flour; ChB, bread with 5% chia whole flour; QB, bread with 25% of quinoa whole flour; MCV, mean corpuscular 
volumen; MCH, mean corpuscular Hb; 
b
FeCl3 dosed at 2.5 µg 
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Figure 1. Plasma hepcidin (Hamp) peptide concentrations in iron-deficient animals (ID) 
and administered with FeCl3 or breads formulated with different flours. Values are 
expressed as mean and range (n=5). 
* 
Indicates statistical differences (P<0.05) in 
relation to iron deficient animals (ID). 
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Figure 2. Hepatic expression of transferring receptor (TfR2) and interleukin (IL)-6 in 
iron deficient (ID) animals and those administered with a supplement of iron (FeCl3) 
alone or the different bread formulations (white bread, WB; whole wheat, WWB; 
amaranth, AB; chia, ChB; quinoa, QB). Results are expressed as mean ± standard 
deviation (n=5). Superscript symbols indicate statistically (p<0.05) significant 
differences (*, TfR2; §, IL-6) relative to controls and between groups of treatment. 
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